(Total Views: 599)
Posted On: 12/24/2022 3:30:13 PM
Post# of 153988
Well darn. Now I can’t find the SAE in the slides that I referenced. It was probably all the peach ‘shine.
But yes I pretty much agree with you…
“ Correct me if I’m wrong but I am not aware of any SAE with Leronlimab that was attributed to the drug and not merely associated with the patient by virtue of other treatments;”
I brought up when I saw it last night because folks debated the 1 SAE mentioned in the call. If memory serves, it was gastrointestinal. (Though I can’t find the slide right now) And that strikes me also as a little harsh to signify as an SAE. And if memory serves, this person dropped out of the trial due their gastrointestinal complication.
But yes I pretty much agree with you…
“ Correct me if I’m wrong but I am not aware of any SAE with Leronlimab that was attributed to the drug and not merely associated with the patient by virtue of other treatments;”
I brought up when I saw it last night because folks debated the 1 SAE mentioned in the call. If memory serves, it was gastrointestinal. (Though I can’t find the slide right now) And that strikes me also as a little harsh to signify as an SAE. And if memory serves, this person dropped out of the trial due their gastrointestinal complication.
(2)
(0)
